13 Facts About Purdue Pharma

Company that became Purdue Pharma was founded in 1892 by medical doctors John Purdue Gray and George Frederick Bingham in New York City as the Purdue Frederick Company.

Purdue Pharma is one of the largest producers of off-patent generic opioids in the US.

Sister companies to Purdue that are controlled by descendants of the Sackler brothers are Napp Pharmaceuticals in the United Kingdom and Mundipharma that are selling opioids globally.

In 2018, Purdue Pharma patented a new form of buprenorphine which controls cravings and is used to treat addiction to opioids such as OxyContin.

Purdue Pharma has been involved in measures against prescription drug abuse, particularly of Oxycontin, an often-abused prescription drug which is among the drugs most commonly cited in connection with overdose deaths.

Related searches

In January 2017, the city of Everett, Washington sued Purdue Pharma based on increased costs for the city from the use of OxyContin as well as Purdue Pharma not intervening when they noted odd patterns of sale of their product, per agreement in the 2007 suit noted above.

The allegations say Purdue Pharma did not follow legal agreements to track suspicious excess ordering or potential black market usage.

Purdue Pharma started the OxyContin "Savings Card" program in 2008, with patients receiving discounts on their first five prescriptions.

In March 2019, Purdue Pharma reached a $270m settlement in a lawsuit filed by Oklahoma, which claimed its opioids contributed to the deaths of thousands of people.

In October 2020, Purdue Pharma agreed to an $8 billion settlement that includes a $2 billion criminal forfeiture, a $3.

An attorney for Purdue Pharma argued that this is necessary for the $6 billion settlement to work and that non-debtor release is not directly prohibited by U S bankruptcy law.

In mid-September 2019, Purdue Pharma filed for bankruptcy in White Plains, New York, a few days after reaching a tentative settlement with state and local governments that were suing the company over the cost of the opioid epidemic.

In early March 2022, members of the Sackler family that own Purdue Pharma struck a new settlement with a group of eight states and the District of Columbia to resolve the litigation.